Literature DB >> 27108252

An integrative data mining approach to identifying adverse outcome pathway signatures.

Noffisat O Oki1, Stephen W Edwards2.   

Abstract

The Adverse Outcome Pathway (AOP) framework is a tool for making biological connections and summarizing key information across different levels of biological organization to connect biological perturbations at the molecular level to adverse outcomes for an individual or population. Computational approaches to explore and determine these connections can accelerate the assembly of AOPs. By leveraging the wealth of publicly available data covering chemical effects on biological systems, computationally-predicted AOPs (cpAOPs) were assembled via data mining of high-throughput screening (HTS) in vitro data, in vivo data and other disease phenotype information. Frequent Itemset Mining (FIM) was used to find associations between the gene targets of ToxCast HTS assays and disease data from Comparative Toxicogenomics Database (CTD) by using the chemicals as the common aggregators between datasets. The method was also used to map gene expression data to disease data from CTD. A cpAOP network was defined by considering genes and diseases as nodes and FIM associations as edges. This network contained 18,283 gene to disease associations for the ToxCast data and 110,253 for CTD gene expression. Two case studies show the value of the cpAOP network by extracting subnetworks focused either on fatty liver disease or the Aryl Hydrocarbon Receptor (AHR). The subnetwork surrounding fatty liver disease included many genes known to play a role in this disease. When querying the cpAOP network with the AHR gene, an interesting subnetwork including glaucoma was identified. While substantial literature exists to support the potential for AHR ligands to elicit glaucoma, it was not explicitly captured in the public annotation information in CTD. The subnetwork from this analysis suggests a cpAOP that includes changes in CYP1B1 expression, which has been previously established in the literature as a primary cause of glaucoma. These case studies highlight the value in integrating multiple data sources when defining cpAOPs for HTS data.
Copyright © 2016. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Adverse outcome pathway (AOP); Glaucoma; Steatosis; cpAOP

Mesh:

Substances:

Year:  2016        PMID: 27108252     DOI: 10.1016/j.tox.2016.04.004

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  15 in total

Review 1.  Progress in data interoperability to support computational toxicology and chemical safety evaluation.

Authors:  Sean Watford; Stephen Edwards; Michelle Angrish; Richard S Judson; Katie Paul Friedman
Journal:  Toxicol Appl Pharmacol       Date:  2019-08-09       Impact factor: 4.219

2.  Advancing the adverse outcome pathway framework-An international horizon scanning approach.

Authors:  Carlie A LaLone; Gerald T Ankley; Scott E Belanger; Michelle R Embry; Geoff Hodges; Dries Knapen; Sharon Munn; Edward J Perkins; Murray A Rudd; Daniel L Villeneuve; Maurice Whelan; Catherine Willett; Xiaowei Zhang; Markus Hecker
Journal:  Environ Toxicol Chem       Date:  2017-06       Impact factor: 3.742

3.  The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.

Authors:  Russell S Thomas; Tina Bahadori; Timothy J Buckley; John Cowden; Chad Deisenroth; Kathie L Dionisio; Jeffrey B Frithsen; Christopher M Grulke; Maureen R Gwinn; Joshua A Harrill; Mark Higuchi; Keith A Houck; Michael F Hughes; E Sidney Hunter; Kristin K Isaacs; Richard S Judson; Thomas B Knudsen; Jason C Lambert; Monica Linnenbrink; Todd M Martin; Seth R Newton; Stephanie Padilla; Grace Patlewicz; Katie Paul-Friedman; Katherine A Phillips; Ann M Richard; Reeder Sams; Timothy J Shafer; R Woodrow Setzer; Imran Shah; Jane E Simmons; Steven O Simmons; Amar Singh; Jon R Sobus; Mark Strynar; Adam Swank; Rogelio Tornero-Valez; Elin M Ulrich; Daniel L Villeneuve; John F Wambaugh; Barbara A Wetmore; Antony J Williams
Journal:  Toxicol Sci       Date:  2019-06-01       Impact factor: 4.849

4.  Public data sources to support systems toxicology applications.

Authors:  Allan Peter Davis; Jolene Wiegers; Thomas C Wiegers; Carolyn J Mattingly
Journal:  Curr Opin Toxicol       Date:  2019-03-11

5.  Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing.

Authors:  Emma Arnesdotter; Eva Gijbels; Bruna Dos Santos Rodrigues; Vânia Vilas-Boas; Mathieu Vinken
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance.

Authors:  Alevtina Y Grishanova; Maria L Perepechaeva
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

Review 7.  In silico toxicology: From structure-activity relationships towards deep learning and adverse outcome pathways.

Authors:  Jennifer Hemmerich; Gerhard F Ecker
Journal:  Wiley Interdiscip Rev Comput Mol Sci       Date:  2020-03-31

Review 8.  Obesity III: Obesogen assays: Limitations, strengths, and new directions.

Authors:  Christopher D Kassotis; Frederick S Vom Saal; Patrick J Babin; Dominique Lagadic-Gossmann; Helene Le Mentec; Bruce Blumberg; Nicole Mohajer; Antoine Legrand; Vesna Munic Kos; Corinne Martin-Chouly; Normand Podechard; Sophie Langouët; Charbel Touma; Robert Barouki; Min Ji Kim; Karine Audouze; Mahua Choudhury; Nitya Shree; Amita Bansal; Sarah Howard; Jerrold J Heindel
Journal:  Biochem Pharmacol       Date:  2022-04-05       Impact factor: 6.100

Review 9.  Adverse outcome pathways: a concise introduction for toxicologists.

Authors:  Mathieu Vinken; Dries Knapen; Lucia Vergauwen; Jan G Hengstler; Michelle Angrish; Maurice Whelan
Journal:  Arch Toxicol       Date:  2017-06-28       Impact factor: 5.153

10.  Identification of potential aryl hydrocarbon receptor ligands by virtual screening of industrial chemicals.

Authors:  Malin Larsson; Domenico Fraccalvieri; C David Andersson; Laura Bonati; Anna Linusson; Patrik L Andersson
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-10       Impact factor: 4.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.